ArticleAnnals of translational medicine2022
The prognosis and risk factors for capecitabine maintenance treatment in metastatic breast cancer: a retrospective comparative cohort study.
Can Tian et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.